[Risk factors of metabolic estrogen-deficiency syndrome in women after menopause and its relationship to hormone replacement therapy].
OBJECTIVE
The aim of the study was to review health state in postmenopausal women with long-term hormone replacement therapy and compare it with health state of control group without hormone replacement therapy. We focused on metabolic estrogen-deficiency syndrome and its influence on risk of cardiovascular disease, risk of osteoporosis and memory dysfunction.


METHODS
Epidemiology study.


METHODS
Department of Obstetrics and Gynecology, University Hospital, Hradec Králové.


METHODS
Pursuant to clinic and laboratory investigation we evaluated blood pressure, BMI, lipid profile, blood sugar, CRP and homocysteine in women with EPT, ET and compared the data it with controls. Due to dual X-ray absorptiometry we determined bone mineral density and by the memory quiz we evaluated memory function in examined postmenopausal women.


RESULTS
Our results indicate that use of hormone replacement therapy in postmenopausal women may be of benefit in cardiovascular risk factors, especially with better plasma lipid profile, blood sugar, atherogenity index, BMI and diastolic blood pressure. We found protective role of HT on decrease of bone mineral density in lumbal spine. We didn't prove this influence in hip. There is no evidence of HT influence on memory dysfunction, but we found, that culture and social life of older women in East Bohemia region is at low level. We did not register any heart attack, stroke and breast cancer under long-term treatment.


CONCLUSIONS
Women with hormone replacement therapy have less of cardiovascular risk factors and better status of mineral bone density than women in control group.
Sormová
I
I
Porodnická a gynekologická klinika LF a FN, Hradec Králové.
Donát
J
J
D000368:Aged; D000369:Aged, 80 and over; D001786:Blood Glucose / Q000032:analysis; D015992:Body Mass Index; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control; D017698:Postmenopause; D012307:Risk Factors
D001786:Blood Glucose; D008055:Lipids